Is Shuttle Pharmaceuticals Stock a Good Investment?
Shuttle Pharmaceuticals Investment Advice | SHPH |
- Examine Shuttle Pharmaceuticals' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Shuttle Pharmaceuticals' leadership team and their track record. Good management can help Shuttle Pharmaceuticals navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Shuttle Pharmaceuticals' business and its evolving consumer preferences.
- Compare Shuttle Pharmaceuticals' performance and market position to its competitors. Analyze how Shuttle Pharmaceuticals is positioned in terms of product offerings, innovation, and market share.
- Check if Shuttle Pharmaceuticals pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Shuttle Pharmaceuticals' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Shuttle Pharmaceuticals stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Shuttle Pharmaceuticals is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Soft | Details | |
Volatility | Very risky | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Shuttle Pharmaceuticals Stock
Researching Shuttle Pharmaceuticals' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book ratio of 1.19. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Shuttle Pharmaceuticals recorded a loss per share of 46.34. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 16th of June 2025.
To determine if Shuttle Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Shuttle Pharmaceuticals' research are outlined below:
| Shuttle Pharmaceuticals had very high historical volatility over the last 90 days | |
| Shuttle Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Shuttle Pharmaceuticals currently holds 1.17 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Shuttle Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Shuttle Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (9.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Shuttle Pharmaceuticals currently holds about 50.44 K in cash with (7.33 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Can HeartCore Enterprises Inc outperform in the next rally - July 2025 News Drivers Fast Moving Stock Watchlists - khodrobank.com |
Shuttle Pharmaceuticals uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Shuttle Pharmaceuticals. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Shuttle Pharmaceuticals' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Shuttle Pharmaceuticals' market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.29 M.Basic technical analysis of Shuttle Stock
As of the 28th of September, Shuttle Pharmaceuticals has the Semi Deviation of 4.54, risk adjusted performance of 0.0365, and Coefficient Of Variation of 2272.53. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Shuttle Pharmaceuticals, as well as the relationship between them.Shuttle Pharmaceuticals' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Shuttle Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Shuttle Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Shuttle Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Shuttle Pharmaceuticals' Outstanding Corporate Bonds
Shuttle Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Shuttle Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Shuttle bonds can be classified according to their maturity, which is the date when Shuttle Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Shuttle Pharmaceuticals' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Shuttle Pharmaceuticals' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0365 | |||
| Market Risk Adjusted Performance | 2.44 | |||
| Mean Deviation | 3.78 | |||
| Semi Deviation | 4.54 | |||
| Downside Deviation | 4.78 | |||
| Coefficient Of Variation | 2272.53 | |||
| Standard Deviation | 5.71 | |||
| Variance | 32.66 | |||
| Information Ratio | 0.0242 | |||
| Jensen Alpha | 0.2312 | |||
| Total Risk Alpha | (0.70) | |||
| Sortino Ratio | 0.029 | |||
| Treynor Ratio | 2.43 | |||
| Maximum Drawdown | 36.1 | |||
| Value At Risk | (6.35) | |||
| Potential Upside | 6.8 | |||
| Downside Variance | 22.88 | |||
| Semi Variance | 20.6 | |||
| Expected Short fall | (4.42) | |||
| Skewness | 1.19 | |||
| Kurtosis | 5.1 |
| Risk Adjusted Performance | 0.0365 | |||
| Market Risk Adjusted Performance | 2.44 | |||
| Mean Deviation | 3.78 | |||
| Semi Deviation | 4.54 | |||
| Downside Deviation | 4.78 | |||
| Coefficient Of Variation | 2272.53 | |||
| Standard Deviation | 5.71 | |||
| Variance | 32.66 | |||
| Information Ratio | 0.0242 | |||
| Jensen Alpha | 0.2312 | |||
| Total Risk Alpha | (0.70) | |||
| Sortino Ratio | 0.029 | |||
| Treynor Ratio | 2.43 | |||
| Maximum Drawdown | 36.1 | |||
| Value At Risk | (6.35) | |||
| Potential Upside | 6.8 | |||
| Downside Variance | 22.88 | |||
| Semi Variance | 20.6 | |||
| Expected Short fall | (4.42) | |||
| Skewness | 1.19 | |||
| Kurtosis | 5.1 |
Consider Shuttle Pharmaceuticals' intraday indicators
Shuttle Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Shuttle Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Shuttle Pharmaceuticals time-series forecasting models is one of many Shuttle Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Shuttle Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Shuttle Stock media impact
There is far too much social signal, news, headlines, and media speculation about Shuttle Pharmaceuticals that are available to investors today. This information is accessible both publicly - through Shuttle Pharmaceuticals' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Shuttle-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Shuttle Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Shuttle Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Shuttle Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Shuttle Pharmaceuticals alpha.
Shuttle Pharmaceuticals Corporate Management
| Michael Starkweather | VP Devel | Profile | |
| CSC MD | Chief CoFounder | Profile | |
| Timothy CPA | Chief Officer | Profile | |
| BBA MBA | Interim Officer | Profile | |
| Gene Esq | General Counsel | Profile | |
| Mira Jung | CoFounder Biology | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shuttle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Shuttle Pharmaceuticals' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.